Dae-Chul Ha

Title: Innovations of Dae-Chul Ha in Pharmaceutical Preparations

Introduction

Dae-Chul Ha is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of composite preparations that enhance drug delivery and patient compliance. With a total of 2 patents, his work focuses on improving the efficacy and stability of medications.

Latest Patents

One of Dae-Chul Ha's latest patents is titled "Composite preparation of mosapride and rabeprazole." This invention relates to a composite preparation that includes various dosage forms of mosapride and rabeprazole. The innovative composite allows for rapid drug release without compromising its effectiveness due to interactions between the two compounds. This results in an improved drug release rate and bioavailability, while also enhancing product stability and reducing the amount of excipient needed. Consequently, this preparation can significantly improve patient compliance due to its manageable dosage size.

Another significant patent is "Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration." This formulation is designed for oral administration and consists of a double-layer structure. It features a fast-release layer for immediate drug action and a sustained-release layer for prolonged effects, ensuring that pharmacological activities are maintained for 24 hours. The formulation utilizes a mixture of high-viscosity and low-viscosity hydroxypropyl methylcellulose (HPMC) to control the dissolution rate across different pH levels in the gastrointestinal tract. Additionally, the total weight of the preparation is kept under 200 mg, ideally between 150 mg and 160 mg, which further aids in improving patient compliance.

Career Highlights

Dae-Chul Ha is currently associated with Korea United Pharm, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to enhancing drug formulations that meet the needs of patients effectively.

Collaborations

Dae-Chul Ha has collaborated with notable colleagues, including Youn Woong Choi and Hee Yong Song, contributing to the advancement of pharmaceutical technologies.

Conclusion

Dae-Chul Ha's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving drug delivery systems. His work not only enhances the efficacy of medications but also significantly improves patient compliance.